Anticoagulant Citrate Dextrose Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Anticoagulant Citrate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, and Dextrose in Water for Injection. It contains no antimicrobial agents, and in each 1000 mL it contains:
| Solution A | Solution B | |
| Total Citrate, expressed as anhydrous citric acid (C6H8O7) | NLT 20.59 g | NLT 12.37 g |
| NMT 22.75 g | NMT 13.67 g | |
| Dextrose (C6H12O6 · H2O) | NLT 23.28 g | NLT 13.96 g |
| NMT 25.73 g | NMT 15.44 g | |
| Sodium (Na) | NLT 4.90 g | NLT 2.94 g |
| NMT 5.42 g | NMT 3.25 g |
Prepare Anticoagulant Citrate Dextrose Solution as follows.
| Solution A | Solution B | |
| Citric Acid (anhydrous) | 7.3 g | 4.4 g |
| Sodium Citrate (dihydrate) | 22.0 g | 13.2 g |
| Dextrose (monohydrate) | 24.5 g | 14.7 g |
| Water for Injection, a sucient quantity to make | 1000 mL | 1000 mL |
Dissolve the ingredients, and mix. Filter the solution until clear, place immediately in suitable containers, and sterilize.
If desired, 8 g and 4.8 g of monohydrated citric acid may be used instead of the indicated, respective amounts of anhydrous citric acid, 19.3 g and 11.6 g of anhydrous sodium citrate may be used instead of the indicated, respective amounts of dihydrated sodium citrate; and 22.3 g and 13.4 g of anhydrous dextrose may be used instead of the indicated, respective amounts of monohydrated dextrose.
2 IDENTIFICATION
A. DEXTROSE
Analysis: Add a few drops of solution (1 in 20) to 5 mL of hot alkaline cupric tartrate TS.
Acceptance criteria: A copious red precipitate of cuprous oxide is formed.
B. IDENTIFICATION TESTS GENERAL, Citrate (191): Meets the requirements when concentrated to one-half its volume
C. IDENTIFICATION TESTS GENERAL, Sodium (191): Meets the requirements when concentrated to one-half its volume
3 ASSAY
3.1 TOTAL CITRATE
Mobile phase, Standard preparation 1, and Chromatographic system: Proceed as directed in Assay for Citric Acid/Citrate and Phosphate
(345)
Sample solution: Pipet 5 mL of Solution into a suitable volumetric flask, and proceed as directed in Assay for Citric Acid/Citrate and Phosphate (345), Sample solution (for the assay of citric acid/citrate).
Analysis
Samples: Standard preparation 1 and Sample solution
Proceed as directed in Assay for Citric Acid/Citrate and Phosphate (345), Procedure.
Calculate the quantity, in g, of anhydrous citric acid (C6H8O7) in the volume of Solution taken:
Result = (ru /rs ) × Cs × (Mr1 /Mr2 ) × F × D
ru = peak area of citrate from the Sample solution
rs = peak area of citrate from Standard preparation 1
Cs = concentration of citrate in Standard preparation 1 (µg/mL)
Mr1 = molecular weight of anhydrous citric acid, 192.12
Mr2 = molecular weight of citrate (C H O ), 189.10
F = conversion factor, 0.000001 g/µg
D = dilution factor
Acceptance criteria: Each 1000 mL should contain 20.59-22.75 g in Solution A and 12.37-13.67 g in Solution B of total citrate expressed as anhydrous citric acid.
3.2 SODIUM
Solution A: Transfer 1.04 g of lithium nitrate to a 1000-mL volumetric flask, add a suitable nonionic surfactant, add water to volume, and mix. This solution contains 15 mEq/1000 mL of lithium.
Standard solution: Transfer 8.18 g of sodium chloride, previously dried at 105° for 2 h to a 1000-mL volumetric flask, dilute with water to volume, and mix. This solution contains 140 mEq/1000 mL of sodium. Transfer 50 µL of this solution to a 10-mL volumetric flask, dilute with Solution A to volume, and mix.
Sample solution: Transfer 25 mL of Solution to a 50-ml volumetric flask, and dilute with water to volume. Transfer 50 µL of this solution to a 10-mL volumetric flask, dilute with Solution A to volume, and mix.
Analysis
Samples: Standard solution and Sample solution
Using a suitable flame photometer, adjusted to read zero with Solution A, concomitantly determine the sodium flame emission readings for the Standard solution and the Sample solution at the wavelength of maximum emission at 589 nm.
Calculate the quantity, in g, of sodium (Na) in 1000 mL of Solution taken:
Result = (ru /rs ) × (Ar /Mr ) × W ×
ru = sodium emission readings from the Sample solution
rs = sodium emission readings from the Standard solution
Ar = atomic weight of sodium, 22.99
Mr = molecular weight of sodium chloride, 58.44
W = weight of sodium chloride taken to make the Standard solution, 8.18 g
F = conversion factor
Acceptance criteria: Each 1000 mL should contain 4.90-5.42 g in Solution A and 2.94-3.25 g in Solution B of sodium.
3.3 DEXTROSE
Analysis: Determine the angular rotation of Solution in a suitable polarimeter tube (see Optical Rotation (781)).
Where Solution is labeled to contain anhydrous dextrose, calculate the percentage, in g/100 mL, of anhydrous dextrose (C6H12O6) in the portion of Solution taken:
Result = (100/F) x A x R
F = midpoint of the specic rotation range for anhydrous dextrose, 52.9°
A = 100 mm divided by the length of the polarimeter tube (mm)
R = observed rotation (°)
Where Solution is labeled to contain dextrose monohydrate, calculate the percentage, in g/100 mL, of dextrose (C6H12O6 · H2O) in the portion of Solution taken:
Result = (100/F) × (Mr1 /Mr2 ) × A × R
F = midpoint of the specic rotation range for anhydrous dextrose, 52.9°
Mr1 = molecular weight for dextrose monohydrate, 198.17
Mr2 = molecular weight for anhydrous dextrose, 180.16
A = 100 mm divided by the length of the polarimeter tube (mm)
R = observed rotation (°)
Acceptance criteria: Each 1000 mL should contain 23.28–25.73 g in Solution A and 13.96–15.44 g in Solution B of dextrose monohydrate.
4 IMPURITIES
CHLORIDE AND SULFATE, Chloride (221): A 10-mL portion shows no more chloride than corresponds to 0.50 mL of 0.020 N hydrochloric acid
(0.0035%).
SPECIFIC TESTS
PH (791): 4.5-5.5
OTHER REQUIREMENTS: Meets the requirements in Injections and Implanted Drug Products (1)
BACTERIAL ENDOTOXINS TEST (85): It contains NMT 5.56 USP Endotoxin Units/mL.
5 ADDITIONAL REQUIREMENTS
Change to read:
PACKAGING AND STORAGE: Preserve in single-dose containers of colorless, transparent Type I or Type II glass or of a suitable plastic material (see
Medical Devices-Bacterial Endotoxin and Pyrogen Tests (161)) (CN 1-May-2019)
LABELING: Label to indicate the number of mL of Solution required per 100 mL of whole blood or the number of mL of Solution required per volume of whole blood to be collected.
USP REFERENCE STANDARDS (11)
USP Citric Acid RS

